Evidence map›Paper›PMID 24632606›Full record

Trial reportOncogene2015

Altered p53 regulation of miR-148b and p55PIK contributes to tumor progression in colorectal cancer.

G Wang, X Cao, S Lai, X Luo, Y Feng, J Wu, Q Ning, X Xia, J Wang, J Gong and 1 more

Abstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in Oncogene, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 35 citations in OpenAlex.

  1. Exploring the Key Signaling Pathways and ncRNAs in Colorectal Cancer.International journal of molecular sciences · 2024
    Review
  2. Article
  3. Article
  4. LPS/Bcl3/YAP1 signaling promotes Sox9Cell death & disease · 2022
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. MicroRNA-148b Acts as a Tumor Suppressor in Cervical Cancer by Inducing G1/S-Phase Cell Cycle Arrest and Apoptosis in a Caspase-3-Dependent Manner.Medical science monitor : international medical journal of experimental and clinical research · 2016
    Article
  15. Colorectal tumor molecular phenotype and miRNA: expression profiles and prognosis.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2016
    Article
  16. Article
  17. MicroRNAs in colorectal carcinoma--from pathogenesis to therapy.Journal of experimental & clinical cancer research : CR · 2016
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

G WangCancer Research Institute, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
X CaoCancer Research Institute, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
S LaiCancer Research Institute, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
X LuoCancer Research Institute, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
Y FengDepartment of Molecular Medical Center, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
J WuDepartment of Molecular Medical Center, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
Q NingDepartment of Infectious Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
X XiaCancer Research Institute, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
J WangDepartment of Immunology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
J GongDepartment of Molecular Medical Center, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
J HuCancer Research Institute, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
Huazhong University of Science and Technology · CNTongji Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs are a class of small non-coding RNAs that regulate the expressions of many genes. Previously, we found that the expression of p55PIK, an isoform of phosphatidylinosotol 3-kinase that has important roles in the regulation of cell cycle, is increased significantly in several types of cancer and contributes to the tumor growth. However, the mechanism for this increased p55PIK expression is not well understood. In this study, we show that miR-148b binds specifically to the 3'-untranslated region of p55PIK and significantly suppresses p55PIK expression. MiR-148b overexpression abolished p55PIK stimulation of cell proliferation and cell cycle progression in colorectal cancer (CRC) cell lines and decreased tumor growth in vivo. Furthermore, we demonstrated that p53 directly activates the transcription of miR-148b by binding to its promoter. In CRC cell lines and tissues, p53 expression was associated with miR-148b expression, and both were negatively associated with p55PIK expression. Our study shows that the p53/miR-148b/p55PIK axis has an important role in cell proliferation and tumor growth, and may represent a novel therapeutic target for treating cancers containing p53 mutations or losses.

Indexed as

Gene Expression Regulation, EnzymologicGene Expression Regulation, NeoplasticCaco-2 CellsCell ProliferationColorectal NeoplasmsFemaleHEK293 CellsHumansMaleMicroRNAsPhosphatidylinositol 3-KinasesRNA, NeoplasmTumor Suppressor Protein p53MicroRNAsMIRN148 microRNA, humanPhosphatidylinositol 3-KinasesPIK3R3 protein, humanRNA, NeoplasmTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID24632606
OpenAlexW2072662409

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.